Rifamycin pr-3

CAS : 21288-98-2

Ref. 3D-WAA28898

Informations sur le produit

• Nom: Rifamycin pr-3
• Marque: Biosynth
• Description: Rifamycin PR-3 is an antibiotic, which is derived from bacterial fermentation, specifically from the bacterium Amycolatopsis rifamycinica. It acts by inhibiting DNA-dependent RNA polymerase, thereby blocking RNA synthesis in susceptible bacteria. This inhibition disrupts protein synthesis, ultimately leading to bacterial cell death. Rifamycin PR-3 is primarily used for the treatment of various bacterial infections, particularly those caused by gram-positive bacteria and certain mycobacteria. Its application is crucial in managing diseases such as tuberculosis, where it targets the Mycobacterium tuberculosis. As a member of the rifamycin class of antibiotics, it is also explored for use in treating refractory cases and in combinations to prevent the development of resistance. This compound’s efficacy in penetrating phagocytic cells makes it an important player in addressing intracellular infections. Scientists continue to study its pharmacokinetics and potential for synergistic combinations, which may expand its utility in infectious disease therapy.

Propriétés chimiques

• Masse moléculaire: 806.9 g/mol
• Formule: C₄₃H₅₄N₂O₁₃
• Degré de pureté: Min. 95%